Due to the sporadic nature of somatic cancers, the number of detected variants is growing, challenging scientists to confidently identify meaningful mutations that could influence or improve decisions in experimental design, at the point of care, or in drug development.
The Human Somatic Mutation Database (HSMD) is a new somatic database developed by Qiagen that contains extensive genomic content relevant to solid tumors and hematological malignancies. Available as a web-based application, this expert-curated resource contains content from over 300,000 real-world clinical oncology cases combined with content from the Qiagen Knowledge Base, providing gene-level, alteration-level, and disease-level information including clinically observed gene and variant frequencies across diseases.
Offered Free by: Qiagen
See All Resources from: Qiagen